Being out of care doesn’t have to be permanent, and many people can restart HIV treatment. The sooner PWH restart treatment, the better, as restarting and staying on HIV treatment can help them reach ...
In a bold step towards tackling the HIV epidemic, the Ministry of Health and Wellness is now considering a pilot programme for the first US Food and Drug Administration-approved injectable HIV ...
A long-acting HIV jab promises near-perfect protection at just $40 a year, but 115 nations must wait for India's approval of generic production ...
Kampala, Uganda | THE INDEPENDENT & AGENCIES | A new long-acting medicine that could make preventing HIV transition might soon be even for poor countries like Uganda thanks to agreements between ...
Kampala — THE INDEPENDENT & AGENCIES | A new long-acting medicine that could make preventing HIV transition might soon be even for poor countries like Uganda thanks to agreements between producers and ...
MedPage Today on MSN
CDC Backs Twice-Yearly Injectable for HIV Prevention
The CDC made a strong recommendation based on a high certainty of evidence to use the long-acting injectable lenacapavir (Yeztugo) for HIV pre-exposure prophylaxis (PrEP), but will that ensure the ...
Research published in The Lancet HIV earlier this year, experts estimated that, if purchased at scale, the cost of generic lenacapavir could range from USD 35 to USD 46 per person-year. Falling to USD ...
AllAfrica on MSN
Zimbabwe: Bulawayo HIV Burden Eases - New Infections Drop 44%
The number of people living with HIV in Bulawayo has declined from 79 711 in 2020 to 76 608 in 2024, as new infections continue to fall in response to significant progress in prevention and treatment.
allAfrica.com on MSN
Kenyan scientist behind controversial Pearl Omega HIV drug passes on
Prof Obel was among Kenya’s most prominent medical researchers in the 1990s and early 2000s, remembered for his controversial but groundbreaking attempts to develop locally produced HIV treatments. - ...
The deals represent a massive price reduction from USD 28 000 to just USD 40 per person per year for medicine that is almost 100% effective in ...
Designed with user accessibility in mindhe app offers voice input, offline access, and will provide guidance to nearby screening facilities once the maps are added.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback